SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001654954-22-011205
Filing Date
2022-08-12
Accepted
2022-08-12 16:39:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13DA tenx_sc13da.htm SC 13D/A 30896
  Complete submission text file 0001654954-22-011205.txt   32506
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Subject) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-58467 | Film No.: 221160753
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Business Address
Doogan Declan (Filed by) CIK: 0001704234 (see all company filings)

Type: SC 13D/A